Intuitive Surgical FAQ: Founding, HQ, and What It Actually Makes

Here's the thing about buying surgical equipment: the questions you ask before signing matter more than almost anything after the contract. In my role coordinating capital equipment procurement for a hospital network, I've handled more than 60 urgent equipment situations over 11 years—and the questions below are the ones that come up every single time. This FAQ covers Intuitive Surgical's founding and HQ, what the company actually builds, and the adjacent devices (CT scanners, spirometers, spinal cord stimulators) that belong in the same procurement conversation.

When Was Intuitive Surgical Founded?

Intuitive Surgical was founded in 1995. The company spun out of SRI International in Menlo Park, California, building on telerobotics research with roots in NASA and military telepresence programs. The founding team included Dr. Fred Moll, a surgeon and entrepreneur. According to the FDA (fda.gov), the first da Vinci system received clearance in 2000, and the platform went on to become a standard in urology and other surgical specialties. The company also went public in 2000, the same year as that first clearance.

"Founded in 1995" isn't a trivia answer. When our team did vendor due diligence, the founding year told us how much clinical evidence and service track record to expect. Nearly 30 years of data is a different risk profile than a five-year track record. That's what you're actually evaluating.

Where Is Intuitive Surgical HQ Located?

Intuitive Surgical's HQ is in Sunnyvale, California, at 1020 Kifer Road. The company grew from a small SRI spin-out into a global organization with manufacturing and repair facilities across multiple countries, and its workforce surpassed 15,000 people in 2024. According to Intuitive Surgical's Q4 2024 shareholder letter, roughly 9,500 da Vinci systems were installed worldwide at year-end 2024. Procedure volume exceeded 2.2 million surgeries globally in 2023 (Source: Intuitive Surgical annual report, 2024).

For procurement teams, the more useful question is where the service network is, not where the corporate HQ sits. Ask your regional rep: how many field service engineers are within 100 miles of your hospital? Where is the nearest instrument depot? Ask for their service response metrics in your region—not national averages, but local performance. Those answers tell you more about your system uptime than the corporate address does.

What Does Intuitive Surgical Actually Make?

From the outside, the da Vinci looks like a single product. The reality is a layered system: a surgeon console, patient-side robotic arms, the vision tower, plus instruments, accessories, and software. The main product lines:

• da Vinci multi-port surgical systems (the X and Xi are current models; the newest, da Vinci 5, received FDA clearance in 2024)
• The Ion endoluminal system, FDA-cleared in 2019, for navigated lung biopsy
• Procedure-specific instruments, endoscopes, and laparoscopic accessories
• Surgeon and OR team training and credentialing programs

The business model matters for your budget: the capital purchase covers the system, but instruments are recurring-use disposables. Procedure volume drives cost-per-case. When you compare total cost of ownership, model instrument costs against your projected case volumes rather than comparing system quotes alone. Training is part of the package, too—surgeons who switch platforms need a ramp-up period, and OR teams have their own certification timeline.

Why Does a CT Scanner Keep Coming Up in Robotic Surgery Discussions?

Because imaging is the roadmap. For the Ion system, a pre-procedural CT scan is used to navigate to peripheral lung nodules that standard bronchoscopes can't reach. For da Vinci procedures, CT and MRI images help surgeons plan approach angles before they step into the OR.

Lung cancer remains the leading cause of cancer death in the U.S. (Source: American Cancer Society, 2025), and the National Lung Screening Trial found low-dose CT screening reduced lung cancer mortality by 20% (Source: National Cancer Institute, 2011). More CT screening means more nodules found—and more nodules mean more biopsy demand. That's why the CT scanner keeps showing up in surgical robotics conversations: it feeds the case volume that these systems depend on. For context, the typical workflow is: a patient gets a low-dose CT, a suspicious nodule gets flagged, then a navigated biopsy is the next step. Without the CT, the biopsy is a shot in the dark.

Where Does a Spirometer Fit in the Surgical Pathway?

A spirometer is a pulmonary function testing device. It measures how much air a patient can exhale and how fast—the key metric being FEV1, forced expiratory volume in one second. It comes up in surgery because pre-operative lung function is a major factor in determining whether a patient is a candidate for thoracic surgery. If FEV1 is too low, the surgical risk may outweigh the benefit.

Spirometry is not an Intuitive product. But in the lung cancer diagnostic pathway, it sits right next to the imaging and biopsy workflow. When we invested in a navigated biopsy system, the pulmonary function lab's capacity turned out to be a scheduling bottleneck we hadn't planned for. Put another way: the device is one link in the chain, but the chain is what matters clinically.

Are Spinal Cord Stimulators Part of Intuitive Surgical's Product Line?

No. This is one of those questions that sounds like it doesn't need asking—but in large health systems, device categories blur all the time. A spinal cord stimulator is a neuromodulation device for chronic pain. Different mechanism, different surgical workflow, different FDA product code.

Spinal cord stimulation is led by companies focused on neuromodulation and pain management—not by surgical robotics firms. Intuitive Surgical focuses on robotic-assisted surgery and endoluminal navigation. When procurement teams are working through capital budgets and similar-sounding technology lands in the same spreadsheet, knowing who makes what prevents costly vendor-qualification mistakes.

How Long Does It Take to Get a Robotic System Operational—and What Happens When It's Down?

Here's where the emergency side of my job comes in. A realistic timeline from contract to first case: three to six months. The installation is the easy part. The slow parts are OR modifications, surgeon training and credentialing, and OR team certification. That timeline doesn't move much, no matter which vendor you're evaluating—which is why the post-installation service plan deserves as much scrutiny as the system itself.

Then there's downtime. In July 2024, one of our CT scanners went down during our busiest surgical week. Our service contract said "best effort, 48 hours" because we'd picked the lower-tier package. We lost a full day of procedures. The finance team's number: roughly $180,000 in contribution margin. You'd think a written SLA would protect you; the reality is response-time guarantees vary significantly between vendors and between service tiers.

What I tell hospital teams now: spend your negotiation energy on the service guarantee, not the sticker price. What I mean is: ask for the response-time SLA in writing, and ask what the penalty is if the vendor misses it. An 8-hour response versus next-business-day can be the difference between a problem and a financial incident when a system is down. You're paying for certainty, not just speed. It's worth more than any discount we could have negotiated.

What's the Biggest Procurement Mistake Hospitals Make?

Buying the system and forgetting everything around it. From the outside, a surgical robot looks like the product. The reality is that outcomes depend on instruments, imaging integration, training, service infrastructure, and the workflow your surgeons already use.

I still kick myself over our first capital purchase: we spent weeks comparing specs, then signed a service contract that didn't match our actual needs. If I'd pushed on response-time guarantees and instrument availability from the start, we'd have avoided a costly delay later. Our policy now requires a service-response review in every capital contract—because of what that one taught us.

Simple. The system is a tool. The ecosystem is the investment. Start with the procedures your surgeons want to grow, then work backward. The technology should serve the clinical plan, not the other way around.

Product availability, FDA clearances, and company data as of 2025; verify current information with Intuitive Surgical or your local representative.